1. COVID-19 Testing in the Era of Modern Neurosurgery: Mitigating Risk in Our Vulnerable Patient Populations
- Author
-
David M. Poetker, Nathan T. Zwagerman, Daniel M Aaronson, and Christopher M. Long
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Psychological intervention ,NP, Nasopharyngeal ,EEA, Endoscopic endonasal approach ,AN, Anterior nares ,Neurosurgical Procedures ,WHO, World Health Organization ,03 medical and health sciences ,0302 clinical medicine ,COVID-19 Testing ,Pandemic ,Health care ,Technical Note ,Medicine ,Humans ,Endoscopic endonasal approach ,Pituitary Neoplasms ,Intensive care medicine ,CDC, Centers for Disease Control and Prevention ,Anterior skull base ,Skull Base ,COVID-19, Coronavirus disease 2019 ,Cerebrospinal Fluid Leak ,business.industry ,SARS-CoV-2 ,COVID-19 ,NMT, Nasal mid-turbinate ,Transsphenoidal ,Increased risk ,Specimen collection ,030220 oncology & carcinogenesis ,Surgery ,Neurology (clinical) ,Neurosurgery ,Nasal Cavity ,business ,030217 neurology & neurosurgery - Abstract
Background The respiratory illness identified as coronavirus disease 2019 (COVID-19) has resulted in a pandemic illness that has changed the face of healthcare. As the COVID-19 pandemic continues, patients have continued to require neurosurgical interventions, and the endoscopic endonasal approach for surgery has continued to be a mainstay treatment of pituitary tumors and anterior skull base lesions. Methods We sought to highlight the current lack of recommendations regarding testing protocols for neurosurgical patients. Results We implemented a novel testing protocol for our patient populations at increased risk and have proposed a model that can be used at other institutions to mitigate the risk of complications associated with some forms of COVID-19 testing. Conclusion Patients with anterior skull base defects may be at risk with current COVID-19 testing protocols, and may benefit from alternative specimen collection strategies.
- Published
- 2021